Oral v Topical Erythromycin Therapies for Chlamydial Conjunctivitis

P. Patamasucon, P. J. Rettig, K. L. Faust, H. T. Kusmiesz, J. D. Nelson

Research output: Contribution to journalArticlepeer-review

26 Scopus citations


Results of oral and topical erythromycin therapy in 41 infants under 4 months of age with chlamydial conjunctivitis were evaluated in a randomized clinical trial. After three weeks of treatment, relapse or reinfection of the eye occurred in four of 19 patients (21%) in the topical therapy group and in three of 22 patients (13.6%) in the oral therapy group (P>.69). In the topical therapy group, chlamydiae were isolated from nasopharyngeal cultures of eight patients (42%) during or after therapy. Chlamydiae were eradicated from the nasopharynx of the six colonized patients treated with oral erythromycin. All relapses responded to a course of oral erythromycin therapy. We conclude that both modes of therapy are comparable for treatment of chlamydial conjunctivitis, but that oral therapy has the advantage of eradicating nasopharyngeal colonization.

Original languageEnglish (US)
Pages (from-to)817-821
Number of pages5
JournalAmerican Journal of Diseases of Children
Issue number9
StatePublished - Sep 1982

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health


Dive into the research topics of 'Oral v Topical Erythromycin Therapies for Chlamydial Conjunctivitis'. Together they form a unique fingerprint.

Cite this